ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Rabies Vaccine (Vero Cell) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-21Q14478
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Rabies Vaccine Vero Cell Market Research Report 2023
BUY CHAPTERS

Global Human Rabies Vaccine (Vero Cell) Market Research Report 2025

Code: QYRE-Auto-21Q14478
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Liaoning Chengda
Guangzhou Nuocheng
Ningbo Rong'an
Hualan Bio-Vaccine
Sanofi Pasteur SA.
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Jilin Huikang Biopharmaceutical Co., Ltd.

Human Rabies Vaccine (Vero Cell) Market Size

The global market for Human Rabies Vaccine (Vero Cell) was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 600 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Human Rabies Vaccine (Vero Cell) Market

Human Rabies Vaccine (Vero Cell) Market

Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine (Vero Cell), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine (Vero Cell).
The Human Rabies Vaccine (Vero Cell) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Rabies Vaccine (Vero Cell) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Vaccine (Vero Cell) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Rabies Vaccine (Vero Cell) Market Report

Report Metric Details
Report Name Human Rabies Vaccine (Vero Cell) Market
Accounted market size in year US$ 428 million
Forecasted market size in 2031 US$ 600 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 0.5ml
  • 1ml
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Liaoning Chengda, Guangzhou Nuocheng, Ningbo Rong'an, Hualan Bio-vaccine, Sanofi Pasteur SA, Bharat Biotech, Bavarian Nordic, Serum Institute of India Pvt., Chengdu Kanghua Biology, Changchun Zhuoyi Biology, Dalian Yali Peak, Jilin Huikang Biopharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Rabies Vaccine (Vero Cell) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Rabies Vaccine (Vero Cell) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Rabies Vaccine (Vero Cell) Market growing?

Ans: The Human Rabies Vaccine (Vero Cell) Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Human Rabies Vaccine (Vero Cell) Market size in 2031?

Ans: The Human Rabies Vaccine (Vero Cell) Market size in 2031 will be US$ 600 million.

Who are the main players in the Human Rabies Vaccine (Vero Cell) Market report?

Ans: The main players in the Human Rabies Vaccine (Vero Cell) Market are Liaoning Chengda, Guangzhou Nuocheng, Ningbo Rong'an, Hualan Bio-vaccine, Sanofi Pasteur SA, Bharat Biotech, Bavarian Nordic, Serum Institute of India Pvt., Chengdu Kanghua Biology, Changchun Zhuoyi Biology, Dalian Yali Peak, Jilin Huikang Biopharmaceutical Co., Ltd.

What are the Application segmentation covered in the Human Rabies Vaccine (Vero Cell) Market report?

Ans: The Applications covered in the Human Rabies Vaccine (Vero Cell) Market report are Hospital, Clinic

What are the Type segmentation covered in the Human Rabies Vaccine (Vero Cell) Market report?

Ans: The Types covered in the Human Rabies Vaccine (Vero Cell) Market report are 0.5ml, 1ml

Recommended Reports

Human Vaccines

Viral And Flu Vaccines

Animal & Specialty Vaccines

1 Human Rabies Vaccine (Vero Cell) Market Overview
1.1 Product Definition
1.2 Human Rabies Vaccine (Vero Cell) by Type
1.2.1 Global Human Rabies Vaccine (Vero Cell) Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5ml
1.2.3 1ml
1.3 Human Rabies Vaccine (Vero Cell) by Application
1.3.1 Global Human Rabies Vaccine (Vero Cell) Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Human Rabies Vaccine (Vero Cell) Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Vaccine (Vero Cell) Revenue 2020-2031
1.4.2 Global Human Rabies Vaccine (Vero Cell) Sales 2020-2031
1.4.3 Global Human Rabies Vaccine (Vero Cell) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Rabies Vaccine (Vero Cell) Market Competition by Manufacturers
2.1 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Rabies Vaccine (Vero Cell) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Rabies Vaccine (Vero Cell), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Rabies Vaccine (Vero Cell), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rabies Vaccine (Vero Cell), Product Type & Application
2.7 Global Key Manufacturers of Human Rabies Vaccine (Vero Cell), Date of Enter into This Industry
2.8 Global Human Rabies Vaccine (Vero Cell) Market Competitive Situation and Trends
2.8.1 Global Human Rabies Vaccine (Vero Cell) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Rabies Vaccine (Vero Cell) Players Market Share by Revenue
2.8.3 Global Human Rabies Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Rabies Vaccine (Vero Cell) Market Scenario by Region
3.1 Global Human Rabies Vaccine (Vero Cell) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2020-2031
3.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2020-2025
3.2.2 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2026-2031
3.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2020-2031
3.3.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2020-2025
3.3.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2026-2031
3.4 North America Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
3.4.1 North America Human Rabies Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2031)
3.4.3 North America Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
3.5.1 Europe Human Rabies Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2031)
3.5.3 Europe Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Region
3.6.1 Asia Pacific Human Rabies Vaccine (Vero Cell) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Rabies Vaccine (Vero Cell) Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Rabies Vaccine (Vero Cell) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
3.7.1 Latin America Human Rabies Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2031)
3.7.3 Latin America Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rabies Vaccine (Vero Cell) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rabies Vaccine (Vero Cell) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2020-2031)
4.1.1 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2020-2025)
4.1.2 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2026-2031)
4.1.3 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2020-2031)
4.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2020-2031)
4.2.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2020-2025)
4.2.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2026-2031)
4.2.3 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2020-2031)
4.3 Global Human Rabies Vaccine (Vero Cell) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2020-2031)
5.1.1 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2020-2025)
5.1.2 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2026-2031)
5.1.3 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2020-2031)
5.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2020-2031)
5.2.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2020-2025)
5.2.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2026-2031)
5.2.3 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2020-2031)
5.3 Global Human Rabies Vaccine (Vero Cell) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Liaoning Chengda
6.1.1 Liaoning Chengda Company Information
6.1.2 Liaoning Chengda Description and Business Overview
6.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolio
6.1.5 Liaoning Chengda Recent Developments/Updates
6.2 Guangzhou Nuocheng
6.2.1 Guangzhou Nuocheng Company Information
6.2.2 Guangzhou Nuocheng Description and Business Overview
6.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolio
6.2.5 Guangzhou Nuocheng Recent Developments/Updates
6.3 Ningbo Rong'an
6.3.1 Ningbo Rong'an Company Information
6.3.2 Ningbo Rong'an Description and Business Overview
6.3.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolio
6.3.5 Ningbo Rong'an Recent Developments/Updates
6.4 Hualan Bio-vaccine
6.4.1 Hualan Bio-vaccine Company Information
6.4.2 Hualan Bio-vaccine Description and Business Overview
6.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolio
6.4.5 Hualan Bio-vaccine Recent Developments/Updates
6.5 Sanofi Pasteur SA
6.5.1 Sanofi Pasteur SA Company Information
6.5.2 Sanofi Pasteur SA Description and Business Overview
6.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolio
6.5.5 Sanofi Pasteur SA Recent Developments/Updates
6.6 Bharat Biotech
6.6.1 Bharat Biotech Company Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolio
6.6.5 Bharat Biotech Recent Developments/Updates
6.7 Bavarian Nordic
6.7.1 Bavarian Nordic Company Information
6.7.2 Bavarian Nordic Description and Business Overview
6.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolio
6.7.5 Bavarian Nordic Recent Developments/Updates
6.8 Serum Institute of India Pvt.
6.8.1 Serum Institute of India Pvt. Company Information
6.8.2 Serum Institute of India Pvt. Description and Business Overview
6.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolio
6.8.5 Serum Institute of India Pvt. Recent Developments/Updates
6.9 Chengdu Kanghua Biology
6.9.1 Chengdu Kanghua Biology Company Information
6.9.2 Chengdu Kanghua Biology Description and Business Overview
6.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
6.9.5 Chengdu Kanghua Biology Recent Developments/Updates
6.10 Changchun Zhuoyi Biology
6.10.1 Changchun Zhuoyi Biology Company Information
6.10.2 Changchun Zhuoyi Biology Description and Business Overview
6.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
6.10.5 Changchun Zhuoyi Biology Recent Developments/Updates
6.11 Dalian Yali Peak
6.11.1 Dalian Yali Peak Company Information
6.11.2 Dalian Yali Peak Description and Business Overview
6.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolio
6.11.5 Dalian Yali Peak Recent Developments/Updates
6.12 Jilin Huikang Biopharmaceutical Co., Ltd.
6.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Information
6.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolio
6.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rabies Vaccine (Vero Cell) Industry Chain Analysis
7.2 Human Rabies Vaccine (Vero Cell) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rabies Vaccine (Vero Cell) Production Mode & Process Analysis
7.4 Human Rabies Vaccine (Vero Cell) Sales and Marketing
7.4.1 Human Rabies Vaccine (Vero Cell) Sales Channels
7.4.2 Human Rabies Vaccine (Vero Cell) Distributors
7.5 Human Rabies Vaccine (Vero Cell) Customer Analysis
8 Human Rabies Vaccine (Vero Cell) Market Dynamics
8.1 Human Rabies Vaccine (Vero Cell) Industry Trends
8.2 Human Rabies Vaccine (Vero Cell) Market Drivers
8.3 Human Rabies Vaccine (Vero Cell) Market Challenges
8.4 Human Rabies Vaccine (Vero Cell) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Liaoning Chengda
Guangzhou Nuocheng
Ningbo Rong'an
Hualan Bio-Vaccine
Sanofi Pasteur SA.
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Jilin Huikang Biopharmaceutical Co., Ltd.
List of Tables
 Table 1. Global Human Rabies Vaccine (Vero Cell) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Rabies Vaccine (Vero Cell) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Rabies Vaccine (Vero Cell) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Rabies Vaccine (Vero Cell) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Rabies Vaccine (Vero Cell) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Rabies Vaccine (Vero Cell) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Rabies Vaccine (Vero Cell) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Rabies Vaccine (Vero Cell), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Rabies Vaccine (Vero Cell), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Rabies Vaccine (Vero Cell), Product Type & Application
 Table 12. Global Key Manufacturers of Human Rabies Vaccine (Vero Cell), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Rabies Vaccine (Vero Cell) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccine (Vero Cell) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Rabies Vaccine (Vero Cell) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Rabies Vaccine (Vero Cell) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2020-2025)
 Table 19. Global Human Rabies Vaccine (Vero Cell) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2026-2031)
 Table 21. Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Rabies Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Rabies Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Rabies Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Rabies Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Rabies Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Rabies Vaccine (Vero Cell) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Rabies Vaccine (Vero Cell) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Rabies Vaccine (Vero Cell) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Rabies Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Rabies Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Rabies Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Rabies Vaccine (Vero Cell) Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Rabies Vaccine (Vero Cell) Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2020-2025)
 Table 53. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2026-2031)
 Table 54. Global Human Rabies Vaccine (Vero Cell) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Rabies Vaccine (Vero Cell) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Human Rabies Vaccine (Vero Cell) Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Rabies Vaccine (Vero Cell) Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2020-2025)
 Table 63. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2026-2031)
 Table 64. Global Human Rabies Vaccine (Vero Cell) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Rabies Vaccine (Vero Cell) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit) by Application (2026-2031)
 Table 70. Liaoning Chengda Company Information
 Table 71. Liaoning Chengda Description and Business Overview
 Table 72. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product
 Table 74. Liaoning Chengda Recent Developments/Updates
 Table 75. Guangzhou Nuocheng Company Information
 Table 76. Guangzhou Nuocheng Description and Business Overview
 Table 77. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product
 Table 79. Guangzhou Nuocheng Recent Developments/Updates
 Table 80. Ningbo Rong'an Company Information
 Table 81. Ningbo Rong'an Description and Business Overview
 Table 82. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product
 Table 84. Ningbo Rong'an Recent Developments/Updates
 Table 85. Hualan Bio-vaccine Company Information
 Table 86. Hualan Bio-vaccine Description and Business Overview
 Table 87. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product
 Table 89. Hualan Bio-vaccine Recent Developments/Updates
 Table 90. Sanofi Pasteur SA Company Information
 Table 91. Sanofi Pasteur SA Description and Business Overview
 Table 92. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product
 Table 94. Sanofi Pasteur SA Recent Developments/Updates
 Table 95. Bharat Biotech Company Information
 Table 96. Bharat Biotech Description and Business Overview
 Table 97. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product
 Table 99. Bharat Biotech Recent Developments/Updates
 Table 100. Bavarian Nordic Company Information
 Table 101. Bavarian Nordic Description and Business Overview
 Table 102. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product
 Table 104. Bavarian Nordic Recent Developments/Updates
 Table 105. Serum Institute of India Pvt. Company Information
 Table 106. Serum Institute of India Pvt. Description and Business Overview
 Table 107. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product
 Table 109. Serum Institute of India Pvt. Recent Developments/Updates
 Table 110. Chengdu Kanghua Biology Company Information
 Table 111. Chengdu Kanghua Biology Description and Business Overview
 Table 112. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product
 Table 114. Chengdu Kanghua Biology Recent Developments/Updates
 Table 115. Changchun Zhuoyi Biology Company Information
 Table 116. Changchun Zhuoyi Biology Description and Business Overview
 Table 117. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product
 Table 119. Changchun Zhuoyi Biology Recent Developments/Updates
 Table 120. Dalian Yali Peak Company Information
 Table 121. Dalian Yali Peak Description and Business Overview
 Table 122. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product
 Table 124. Dalian Yali Peak Recent Developments/Updates
 Table 125. Jilin Huikang Biopharmaceutical Co., Ltd. Company Information
 Table 126. Jilin Huikang Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product
 Table 129. Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Human Rabies Vaccine (Vero Cell) Distributors List
 Table 133. Human Rabies Vaccine (Vero Cell) Customers List
 Table 134. Human Rabies Vaccine (Vero Cell) Market Trends
 Table 135. Human Rabies Vaccine (Vero Cell) Market Drivers
 Table 136. Human Rabies Vaccine (Vero Cell) Market Challenges
 Table 137. Human Rabies Vaccine (Vero Cell) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Rabies Vaccine (Vero Cell)
 Figure 2. Global Human Rabies Vaccine (Vero Cell) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Rabies Vaccine (Vero Cell) Market Share by Type: 2024 & 2031
 Figure 4. 0.5ml Product Picture
 Figure 5. 1ml Product Picture
 Figure 6. Global Human Rabies Vaccine (Vero Cell) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Rabies Vaccine (Vero Cell) Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Human Rabies Vaccine (Vero Cell) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Rabies Vaccine (Vero Cell) Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Human Rabies Vaccine (Vero Cell) Sales (2020-2031) & (K Units)
 Figure 13. Global Human Rabies Vaccine (Vero Cell) Average Price (US$/Unit) & (2020-2031)
 Figure 14. Human Rabies Vaccine (Vero Cell) Report Years Considered
 Figure 15. Human Rabies Vaccine (Vero Cell) Sales Share by Manufacturers in 2024
 Figure 16. Global Human Rabies Vaccine (Vero Cell) Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Human Rabies Vaccine (Vero Cell) Players: Market Share by Revenue in Human Rabies Vaccine (Vero Cell) in 2024
 Figure 18. Human Rabies Vaccine (Vero Cell) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Human Rabies Vaccine (Vero Cell) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)
 Figure 21. North America Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)
 Figure 22. United States Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)
 Figure 25. Europe Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2020-2031)
 Figure 33. China Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Human Rabies Vaccine (Vero Cell) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Human Rabies Vaccine (Vero Cell) by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Human Rabies Vaccine (Vero Cell) by Type (2020-2031)
 Figure 52. Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Human Rabies Vaccine (Vero Cell) by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Human Rabies Vaccine (Vero Cell) by Application (2020-2031)
 Figure 55. Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit) by Application (2020-2031)
 Figure 56. Human Rabies Vaccine (Vero Cell) Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Human Rabies Vaccine Market Research Report 2024
Global Rabies Vaccination Market Research Report 2025
Global Human Rabies Vaccination Market Research Report 2025
Rabies Vaccine Market
Global Vero Cell Rabies Vaccines for Human Market Research Report 2025
Human Diploid Cellular Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rabies Vaccine for Pets Market Research Report 2024
Companion Animals Rabies Veterinary Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Freeze dried Human Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Rabies Treatment Market Insights Forecast to 2030
Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
SARS Cov 2 Vaccine Vero Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Anti Rabies Vaccine Market Research Report 2024
Global Human Diploid Cell Rabies Vaccine Market Research Report 2024
Global Rabies Diagnostics Market Research Report 2024
Global Passive Immunizing Drugs against Rabies Market Research Report 2024
Global Rabies Antiserum Market Research Report 2024
Rabies Virus Vaccine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Rabies Vaccine Antibody Testing Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions